Companies House does not verify the accuracy of the information filed

Advanced company search

JELLAGEN PHARMA LIMITED

Company number SC812293

Follow this company File for this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Company Results (links open in a new window)
Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
17 Jun 2024	TM01	Termination of appointment of Thomas-Paul Descamps as a director on 17 June 2024	View PDF Termination of appointment of Thomas-Paul Descamps as a director on 17 June 2024 - link opens in a new window - 1 page (1 page)
17 Jun 2024	AP01	Appointment of Dr Andrew Spragg as a director on 17 June 2024	View PDF Appointment of Dr Andrew Spragg as a director on 17 June 2024 - link opens in a new window - 2 pages (2 pages)
31 May 2024	AA01	Current accounting period shortened from 31 May 2025 to 31 December 2024	View PDF Current accounting period shortened from 31 May 2025 to 31 December 2024 - link opens in a new window - 1 page (1 page)
31 May 2024	NEWINC	Incorporation MODEL ARTICLES ‐ Model articles adopted (Amended Provisions) Statement of capital on 2024-05-31 GBP 100	View PDF Incorporation MODEL ARTICLES ‐ Model articles adopted (Amended Provisions) Statement of capital on 2024-05-31 GBP 100 - link opens in a new window - 27 pages (27 pages)

Tell us what you think of this service Is there anything wrong with this page?